Madrid, Spain

Teresa D Matas


Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1992-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Teresa D. Matas: Innovator in Antifungal and Immunosuppressant Research**

Introduction

Teresa D. Matas is a distinguished inventor based in Madrid, Spain, recognized for her significant contributions to the fields of antifungal agents and immunosuppressants. With a total of three patents to her name, her work demonstrates a profound commitment to addressing critical medical challenges.

Latest Patents

Among her notable inventions is a novel antifungal agent. This compound, having a specific chemical formula, exhibits remarkable antifungal activity, which could play a vital role in treating various fungal infections. In addition, Teresa has developed a innovative process for producing FK-506, a macrolide immunosuppressant. This process utilizes the microorganism Streptomyces sp. (Merck Culture Collection No. MA 6858, ATCC No. 55098) under fermentation conditions. FK-506 is particularly beneficial in preventing organ transplant rejection, making it invaluable in medical settings for procedures such as bone marrow and heart transplants.

Career Highlights

Teresa's impressive portfolio is backed by her association with Merck & Company, Inc., a leader in pharmaceutical innovation. Within this esteemed organization, she leverages her expertise to enhance product development and contribute to groundbreaking research initiatives.

Collaborations

In her professional journey, Teresa has collaborated with eminent colleagues including Francis J. Dumont and George M. Garrity. Working alongside these talented individuals has further enriched her research, fostering a collaborative environment that enhances creativity and innovation.

Conclusion

Teresa D. Matas exemplifies the spirit of innovation through her valuable contributions to antifungal and immunosuppressant research. With her ongoing work at Merck & Company, Inc., she continues to pave the way for advancements that could significantly impact patient care and treatment options in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…